Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Arjo AB ( ($SE:ARJO.B) ) has shared an update.
Arjo AB’s interim report for Q2 2025 highlights a 3.0% organic growth in net sales, despite a slight decline in overall sales compared to the previous year. The company launched a new acute care stretcher, Sentego, and reported strong performance in the US and Canada, with double-digit growth. Arjo is focusing on cost efficiency to counteract currency and tariff impacts, and anticipates strong sales development in the latter half of 2025, supported by a robust order book and new product launches.
The most recent analyst rating on ($SE:ARJO.B) stock is a Sell with a SEK28.00 price target. To see the full list of analyst forecasts on Arjo AB stock, see the SE:ARJO.B Stock Forecast page.
More about Arjo AB
Arjo AB operates in the healthcare industry, focusing on providing medical devices and solutions that enhance patient care and improve healthcare outcomes. The company specializes in products such as patient handling equipment, hygiene systems, and medical beds, with a strong market presence in North America and Europe.
Average Trading Volume: 822,899
Current Market Cap: SEK9.34B
For a thorough assessment of ARJO.B stock, go to TipRanks’ Stock Analysis page.